Surgical management of vestibular schwannomas after failed radiation treatment.

Neurosurg Rev

Division of Neurosurgery, Duke University Medical Center, 1000 Trent Drive 4520 Hosp South, Durham, NC, 27710, Box 3807, USA.

Published: April 2016

AI Article Synopsis

  • Increased use of stereotactic radiation treatments for vestibular schwannoma (VS) has led to observable tumor regrowth and new symptoms in patients following treatment.
  • Out of 39 patients who underwent surgery after SRT failure, 92.3% experienced tumor growth, and common symptoms that worsened included deafness (41%) and dizziness (35.9%).
  • Surgical outcomes indicated that GTR was possible in only 33.3% of cases, with complications linked to increased adhesions and fragile nerve structures, highlighting the complexities of reoperating on patients who have previously undergone SRT.

Article Abstract

Increasing numbers of patients with vestibular schwannoma (VS) have been treated with focused-beam stereotactic radiation treatment (SRT) including Gamma knife, CyberKnife, X-knife, Novalis, or proton beam therapy. The purpose of this study was to document the incidence of tumor regrowth or symptoms that worsened or first developed following SRT and to discuss surgical strategies for patients who have failed SRT for VS. A consecutive series of 39 patients with SRT failed VS were surgically treated. Clinical symptoms, tumor regrowth at follow-up, intraoperative findings, and surgical outcome were evaluated. There were 15 males and 24 females with a mean age of 51.8 years. Thirty-six patients (92.3%) demonstrated steady tumor growth after SRT. Two (5.1%) patients with slight increase of the mass underwent surgical resection because of development of unbearable facial pain. Symptoms that worsened or newly developed following SRT in this series were deafness (41%), dizziness (35.9%), facial numbness (25.6%), tinnitus (20.5%), facial nerve palsy (7.7%), and facial pain (7.7%). Intraoperative findings demonstrated fibrous changes of the tumor mass, cyst formation, and brownish-yellow or purple discoloration of the tumor capsule. Severe adhesions between the tumor capsule and cranial nerves, vessels, and the brainstem were observed in 69.2%. Additionally, the facial nerve was more fragile and irritable in all cases. Gross total resection (GTR) was achieved in 33.3% of patients, near-total resection (NTR) in 35.9%, and subtotal resection (STR) in 30.8% of patients. New facial nerve palsy was seen in seven patients (19.4%) postoperatively. Our findings suggest that patients with VS who fail SRT with either tumor progression or worsening of clinical symptoms will have an increased rate of adhesions to the neurovascular structures and may have radiation-influenced neuromalacia. Salvage surgery of radiation-failed tumors is more difficult and will have a higher risk of postoperative complications. Radical total resection may not be feasible, and conservative modality of subtotal resection needs to be considered to avoid new neurologic deficits.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10143-015-0690-7DOI Listing

Publication Analysis

Top Keywords

facial nerve
12
patients
9
radiation treatment
8
tumor regrowth
8
symptoms worsened
8
developed srt
8
clinical symptoms
8
intraoperative findings
8
facial pain
8
nerve palsy
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!